GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Resmed Inc. (RMD) [hlAlert]

Rating:
Hold RMD
up 13.69 %

Resmed Inc. (RMD) downgraded to Hold with price target $53 by Jefferies & Co

Posted on: Friday,  Nov 6, 2009  9:25 AM ET by Jefferies & Co

Jefferies & Co rated Hold Resmed Inc. (NYSE: RMD) on 11/06/2009. Previously Jefferies & Co rated Buy Resmed Inc. (NYSE: RMD) on
02/06/2009., when the stock price was $21.11. Since then, Resmed Inc. has gained 13.69% as of 11/06/2009's recent price of $24.00.
If you would have followed the previous Jefferies & Co's recommendation on RMD, you would have gained 13.69% of your investment in 273 days.

ResMed Inc. is a holding company. Through its subsidiaries, the Company develops, manufactures and distributes medical equipment for treating, diagnosing and managing sleep-disordered breathing (SDB) and other respiratory disorders, including obstructive sleep apnea (OSA). It has developed nasal continuous positive airway pressure (CPAP) as a non-invasive treatment for OSA. CPAP systems deliver pressurized air, typically through a nasal mask, to prevent collapse of the upper airway during sleep. The Company has developed a number of products for SDB and other respiratory disorders, including airflow generators, diagnostic products, mask systems, headgear and other accessories. ResMed Inc. sells its products in over 70 countries through a combination of wholly owned subsidiaries and independent distributors to sleep clinics, home healthcare dealers and third-party payers. On April 30, 2009, it acquired Respicure Medsys PVT.LTD. In October 2009, ResMed Inc. acquired Laboratoires Narval.

Our focus on growing and mid-sized companies enables us to identify unique investment ideas, which can make the difference in a tough market. Jefferies' research effort covers U.S. & International equity, high yield, convertibles, investment grade fixed income and post-reorganization securities, as well as special situations and quantitative research. The more than 120-person team of research professionals covers over 1,200 companies in more than 40 industries worldwide. Our analysts focus on identifying emerging industry themes and dig deeper to provide in-depth, thought provoking, objective research. Our analysts use a variety of quantitative and qualitative tools, integrating field analysis, proprietary channel checks and ongoing dialogue with the managements of the companies they cover. We utilize the latest technologies to deliver a research product that is timely, differentiated, and tailored to each customer's needs. Regular client access to companies and their management teams is provided through a wide variety of Jefferies hosted industry conferences, company management meetings and on-site tours.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/6/2009 9:25 AM Hold
None
24.00 26.50
as of 12/31/2009
1 Week   
1 Month   
3 Months up  6.19 %
1 YTD up  28.06 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/6/2009 8:25 AM Buy
None
21.11 23.50
11/19/2008 8:25 AM Buy
None
17.87 20.50

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy